Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
Ekblad, Lars; Kjellström, Johan; Johnsson, Anders
Anti-Cancer Drugs: June 2010 - Volume 21 - Issue 5 - pp 523-531
- DOI:
http://dx.doi.org/10.1097/CAD.0b013e328337b867